PROMIX Trial Group

PROMIX Trial Group is a clinical research organization and academic research entity focused on the management and execution of clinical trials, particularly in the field of oncology. The group is well-known for its involvement in the PROMIX trial, a multicenter study evaluating the efficacy of neoadjuvant chemotherapy in breast cancer patients using molecular profiling. They provide specialized services in trial design, patient recruitment, and data management for complex clinical studies. By bridging the gap between academic research and clinical application, the group aims to advance personalized medicine through rigorous clinical validation.